NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Brocade

(BRCD)

was upgraded at Pacific Crest to Sector Perform. CEO resignation increases the chances of a takeover or company breakup, Pacific Crest said.

Cerner

(CERN) - Get Report

was downgraded at Morgan Stanley from Overweight to Equal-Weight. Bookings growth could slow down in the coming quarters, Morgan Stanley said.

Cabot Oil & Gas

(COG) - Get Report

was upgraded at JP Morgan from Neutral to Overweight. $54.50 price target. Company can grow faster than its peers over the coming quarters, JP Morgan said.

Cymer

(CYMI)

was initiated with a Hold rating at Deutsche Bank. Valuation call, based on a $58 price target, Deutsche Bank said.

McKesson

(MCK) - Get Report

was downgraded at Morgan Stanley from Overweight to Equal-Weight. Company is seeing fewer new exclusive generics, Morgan Stanley said.

Molycorp

(MCP)

was downgraded from Buy to Hold at Dahlman Rose. Estimates were also cut, following the recent bond offering, Dahlman Rose said.

Walgreen

(WAG)

was upgraded at Morgan Stanley from Underweight to Equal-Weight. ESRX overhang has been removed, but European risks remain. Morgan Stanley said.

Wellpoint

(WLP)

was downgraded at Morgan Stanley from Overweight to Equal-Weight. Company continues to disappoint with execution, Morgan Stanley said.

STOCK COMMENTS / EPS CHANGES

Agilent Technologies

(A) - Get Report

numbers were cut at Citigroup. Shares are now seen reaching $47. Estimates were also lowered as macro issues lead weak results, Citi said. Buy rating.

Aeropostale

(ARO)

estimates were lowered at UBS through 2014. Expect continued margin pressure and share repos likely minimal NT, UBS said. Neutral rating and $14 price target.

Aeropostale estimates, target reduced at Brean Murray. Estimates were cut through 2014. Company lowered its guidance again, Brean Murray said. Buy rating and nwe $18 price target.

Brocade numbers were raised at BMO Capital Markets. Shares are now senn reaching $7. Estimates were also increased on modest increase in revenues and operating margins, BMO said. Market Perform rating.

FedEx

(FDX) - Get Report

estimates, target cut were at Goldman Sachs. Estimates were reduced through 2015. Company should see slower volume growth, Goldman said. Buy rating and new $101 price target.

Gap

(GPS) - Get Report

numbers were raised at UBS. Shares of GPS are now seen reaching $35. Estimates were also increased on improved execution, UBS said. Neutral rating.

Gap estimates, target upped at Lazard. Estimates were boosted through 2013. Company is carrying a lot of sales momentum into the second half of the year, Lazard said. Buy rating and new $45 price target.

Home Depot

(HD) - Get Report

numbers raised at UBS. Shares are now seen reaching $63. Estimates also increased as second half of 2012 sets up well, UBS said. Buy rating.

Marvell Technology

(MRVL) - Get Report

numbers were reduced at Credit Suisse. Estimates were cut through 2014. Company lowered its guidance, Credit Suisse said. Outperform rating and new $18 price target.

Micron

(MU) - Get Report

estimates, price target were cut at Pacific Crest. Shares are now seen reaching $10. Estimates were also reduced, given a weaker PC outlook.

Constellation Brands

(STZ) - Get Report

numbers were boosted at Bank of America/Merrill Lynch. Estimates were also raised, as a tight wine supply should boost pricing, BofA/Merrill said. Buy rating.

SUPERVALU

(SVU)

price target was cut at Citigroup to $3. Reflects deteriorating fundamentals and intesifying competition, Citi said. Neutral rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>The Other Cisco: Investors Ignore the Good

>>United: We Did Not Lose Anybody

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.